Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults

Author： Rustgi V.K.   Schleupner C.J.   Krause D.S.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.13, Iss.17, 1995-12, pp. : 1665-1668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age

By The Kaiser-UCLA Vaccine Study Group   Greenberg D.P.   Vadheim C.M.   Marcy S.M.   Partridge S.   Jing J.   Chung-Yin C.   Greene T.   Margolis H.S.   Ward J.I.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 811-816

Elsevier

Access to resources Recommend Favorite

Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age

By Aristegui J.   Dal-Re R.   Garrote E.   Gonzalez A.   Arrate J.-P.   Perez A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1976-1981

Elsevier

Access to resources Recommend Favorite

Newborn universal immunisation against hepatitis B: immunogenicity and reactogenicity of simultaneous administration of diphtheria/tetanus/pertussis (DTP) and oral polio vaccines with hepatitis B vaccine at 0, 2 and 6 months of age

By Aristegui J.   Muniz J.   Legorburu A.P.   Imaz M.   Arrate J.P.   Suarez M.D.   Goiri M.D.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 973-977

Elsevier

Access to resources Recommend Favorite

Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP~T-HBs) administered at 2, 4, 6 and 12-14 months of age

By Liese J.G.   Stojanov S.   Berut F.   Minini P.   Harzer E.   Jow S.   Schodel F.   Boslego J.   Hoffenbach A.   Kronwitter A.   Belohradsky B.H.   Munich Vaccine Study Group  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 448-454

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus b conjugate vaccine administered to infants at two, four and six months of age

By Mills E.   Gold R.   Thipphawong J.   Barreto L.   Guasparini R.   Meekison W.   Cunning L.   Russell M.   Harrison D.   Boyd M.   Fang X.  

Vaccine, Vol. 16, Iss. 6, 1998-04 ,pp. : 576-585

Elsevier

Access to resources Recommend Favorite